0001209191-19-012023.txt : 20190221 0001209191-19-012023.hdr.sgml : 20190221 20190221163217 ACCESSION NUMBER: 0001209191-19-012023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190220 FILED AS OF DATE: 20190221 DATE AS OF CHANGE: 20190221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Breeden Richard C CENTRAL INDEX KEY: 0001300622 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37614 FILM NUMBER: 19622280 MAIL ADDRESS: STREET 1: 100 SOUTH WACKER STREET 2: SUITE 1800 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STERIS plc CENTRAL INDEX KEY: 0001624899 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 981203539 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: RUTHERFORD HOUSE STREET 2: STEPHENSONS WAY CITY: DERBY STATE: X0 ZIP: DE21 6LY BUSINESS PHONE: (440) 354-2600 MAIL ADDRESS: STREET 1: RUTHERFORD HOUSE STREET 2: STEPHENSONS WAY CITY: DERBY STATE: X0 ZIP: DE21 6LY FORMER COMPANY: FORMER CONFORMED NAME: Steris plc DATE OF NAME CHANGE: 20151102 FORMER COMPANY: FORMER CONFORMED NAME: New STERIS Ltd DATE OF NAME CHANGE: 20141125 FORMER COMPANY: FORMER CONFORMED NAME: Solar New HoldCo Ltd DATE OF NAME CHANGE: 20141112 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-02-20 0 0001624899 STERIS plc STE 0001300622 Breeden Richard C C/O RUTHERFORD HOUSE, STEPHENSONS WAY CHADDESDEN DERBY X0 DE21 6LY UNITED KINGDOM 1 0 0 0 Ordinary Shares, 10 pence par value 2019-02-20 4 M 0 3609 28.08 A 28548 D Ordinary Shares, 10 pence par value 72242 I See Footnote Below. Director Stock Option (right to buy) 28.08 2019-02-20 4 M 0 3609 0.00 D 2019-07-31 Ordinary Shares 3609 0 D Richard C. Breeden is the managing member of Breeden Capital Partners LLC, managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC is in turn the general partner of Breeden Partners L.P. (the "Fund"). Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares of STERIS plc owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. This option to purchase 3,609 STERIS plc ordinary shares, which is fully vested, was received in conjunction with the "Combination" of STERIS Corporation and Synergy Health, Ltd. in exchange for an option to purchase 3,609 STERIS Corporation common shares for $28.08 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 2019-02-21